Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gadina

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Nature Reviews. Drug Discovery|December 29, 2017
JAK inhibition as a therapeutic strategy for immune and inflammatory diseasesDaniella M Schwartz, Yuka Kanno, Alejandro Villarino, et al.
Nature Reviews. Drug Discovery|November 7, 2017
JAK inhibition as a therapeutic strategy for immune and inflammatory diseasesDaniella M Schwartz, Yuka Kanno, Alejandro Villarino, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2021
JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibitionYiming Luo, Madison Alexander, Massimo Gadina, et al.
Nature Reviews. Immunology|November 27, 2023
Author Correction: Protein kinases: drug targets for immunological disordersLeslie Castelo-Soccio, Hanna Kim, Massimo Gadina, et al.
Nature Reviews. Immunology|May 15, 2023
Protein kinases: drug targets for immunological disordersLeslie Castelo-Soccio, Hanna Kim, Massimo Gadina, et al.
Nature Reviews. Rheumatology|September 9, 2024
JAK inhibitor selectivity: new opportunities, better drugs?Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, et al.
The Journal of Allergy and Clinical Immunology|June 20, 2026
The Evolving Landscape of JAK-STAT Inhibition in the Treatment of Immune Mediated Inflammatory DiseasesBenjamin A Turturice, Dale Kobrin, Alexandra F Freeman, et al.
Annual Review of Medicine|January 15, 2015
The JAK-STAT pathway: impact on human disease and therapeutic interventionJohn J O'Shea, Daniella M Schwartz, Alejandro V Villarino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2020
Translating JAKs to JakinibsMassimo Gadina, Danielle A Chisolm, Rachael L Philips, et al.
Rheumatology (Oxford, England)|February 27, 2019
Janus kinases to jakinibs: from basic insights to clinical practiceMassimo Gadina, Mimi T Le, Daniella M Schwartz, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Nature Reviews. Drug Discovery|December 29, 2017
JAK inhibition as a therapeutic strategy for immune and inflammatory diseasesDaniella M Schwartz, Yuka Kanno, Alejandro Villarino, et al.
Nature Reviews. Drug Discovery|November 7, 2017
JAK inhibition as a therapeutic strategy for immune and inflammatory diseasesDaniella M Schwartz, Yuka Kanno, Alejandro Villarino, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2021
JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibitionYiming Luo, Madison Alexander, Massimo Gadina, et al.
Nature Reviews. Immunology|November 27, 2023
Author Correction: Protein kinases: drug targets for immunological disordersLeslie Castelo-Soccio, Hanna Kim, Massimo Gadina, et al.
Nature Reviews. Immunology|May 15, 2023
Protein kinases: drug targets for immunological disordersLeslie Castelo-Soccio, Hanna Kim, Massimo Gadina, et al.
Nature Reviews. Rheumatology|September 9, 2024
JAK inhibitor selectivity: new opportunities, better drugs?Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, et al.
The Journal of Allergy and Clinical Immunology|June 20, 2026
The Evolving Landscape of JAK-STAT Inhibition in the Treatment of Immune Mediated Inflammatory DiseasesBenjamin A Turturice, Dale Kobrin, Alexandra F Freeman, et al.
Annual Review of Medicine|January 15, 2015
The JAK-STAT pathway: impact on human disease and therapeutic interventionJohn J O'Shea, Daniella M Schwartz, Alejandro V Villarino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2020
Translating JAKs to JakinibsMassimo Gadina, Danielle A Chisolm, Rachael L Philips, et al.
Rheumatology (Oxford, England)|February 27, 2019
Janus kinases to jakinibs: from basic insights to clinical practiceMassimo Gadina, Mimi T Le, Daniella M Schwartz, et al.
Pageof 13